Recombinant SARS-CoV-2 Spike Glycoprotein RBD (Kappa B.1.617/B.1.617.1/B.1.617.3 Variant) (Fc Tag), Unconjugated

Product Overview

• Article Name: Recombinant SARS-CoV-2 Spike Glycoprotein RBD (Kappa B.1.617/B.1.617.1/B.1.617.3 Variant) (Fc Tag), Unconjugated
• Biozol Catalog Number: ABC-A318168-100
• Supplier Catalog Number: A318168-100
• Alternative Catalog Number: ABC-A318168-100
• Manufacturer: Antibodies.com
• Category: Proteine/Peptide
• Application: SDS-PAGE
• Conjugation: Unconjugated
• Alternative Names: sars-cov-2

Product Description

Consists of amino acids Arg319-Phe541 of SARS-CoV-2 Spike Glycoprotein RBD (Kappa B.1.617/B.1.617.1/B.1.617.3 Variant) containing the following mutations: L452R and E484Q. The human Fc tag consists of amino acids Glu99-Ala330.

Product Properties

• Concentration: Reconstitution dependent.
• Molecular Weight: The protein has a predicted molecular mass of 51.2 kDa after removal of the signal peptide. The apparent molecular mass of RBD(L452Rand E484Q)-hFc is approximately 55-70 kDa due to glycosylation.
• Tag: C-terminal Human Fc Tag
• Buffer: Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%-8% Trehalose is added as a protectant before lyophilization.
• Expression System: HEK293 cells
• Purity: > 95% by SDS-PAGE and Coomassie blue staining.
• Form: Lyophilized
• Sequence: S protein RBD (L452Rand E484Q) (Arg319-Phe541) + hFc (Glu99-Ala330)
• Target: SARS-CoV-2 Spike Glycoprotein RBD